Google Übersetzer
Vor Biopharma Inc.
About
15.20USD+1.10 +7.80%
Closed • Updated at 18:01 GMT+00:00Market Cap$823.63M
Volume424.3K
Beta9.89
RSI50.79
Vor Biopharma Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
May 13 2026
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Mar 30 2026
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 30 2026
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
Mar 27 2026
Vor Bio Announces $75 Million Private Placement with TCGX
Recent Videos
VOR BIOPHARMA INC 2025 annual report
Apr 08, 2026
How to Invest in Vor BioPharma Inc (VOR) Step by Step
Apr 03, 2026
POTENTIAL BREAKOUT | VOR STOCK ANALYSIS | VOR BIOPHARMA STOCK
Apr 02, 2026
VOR STOCK : POTENTIAL BOUNCEBACK | VOR BIOPHARMA STOCK
Mar 28, 2026
Community Chat
Ask AI
Try asking